Effects of neurofeed back training on inhibitory capacities in ADHD children: A single-blind, randomized, placebo-controlled study

Journal of Neurotherapy

Volumn 14, Issue 3, 2010, Pages 229-242

  Perreau Linck, Elisabeth ^a   Lessard, Nadia ^b   Lévesque, Johanne ^c   Beauregard, Mario ^a,d  

^a CENTRE DE RECHERCHE EN NEUROPSYCHOLOGIE ET COGNITION   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c Institut PsychoNeuro   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

ADHD; Inhibition; Motivation; Neurofeedback; Placebo controlled study; Randomized; Single blind

Indexed keywords

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MALE; MOTIVATION; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; PRIORITY JOURNAL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SENSORIMOTOR FUNCTION; SINGLE BLIND PROCEDURE; TRAINING;

EID: 77955816295     PISSN: 10874208     EISSN: 1530017X     Source Type: Journal    
DOI: 10.1080/10874208.2010.501514     Document Type: Article

References (52)

1. Abikoff, H., Hechtman, L., Klein, R. G., Weiss, G., Fleiss, K., Etcovitch, J., et al. (2004). Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of American Academy of Child & Adolescent Psychiatry, 43, 802-811.
2. American Psychiatric Association. (2000). Diagnostic and statisticalmanual ofmental disorders (4th ed., text rev.). Washington, DC: American Psychiatric Press.
3. Arns, M., de Ridder, S., Strehl, U., Breteler, M., & Coenen, A. (2009). Efficacy of neurofeedback treatment in ADHD: The effects on inattention, impulsivity and hyperactivity: A meta-analysis. Clinical EEG and Neuroscience, 40, 180-189.
4. Barkley, R. A. (1997). Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychological Bulletin, 21(1), 65-94.
5. Beauregard, M. (2007). Mind does really matter: Evidence from neuroimaging studies of emotional self-regulation, psychotherapy, and placebo effect. Progress in Neurobiology, 81, 218-236.
6. Beauregard, M. (2009). Effect of mind on brain activity: Evidence from neuroimaging studies of psychotherapy and placebo effect. Nord Journal of Psychiatry, 63(1), 5-16.
7. Biederman, J. (2002). Practical considerations in stimulant drug selection for the attention-deficit=hyperactivity disorder patient-efficacy, potency and titration. Today's Therapeutic Trends, 20, 311-328.
8. Biederman, J., Monuteaux, M. C., Mick, E., Spencer, T., Wilens, T. E., Silva, J. M., et al. (2006). Young adult outcome of attention deficit hyperactivity disorder: A controlled 10-year follow-up study. Psychological Medicine, 36, 167-179.
9. Brickenkamp, R., & Zillmer, E. (1998). The D2 Test of Attention manual. Berlin: Hogrefe & Huber.
10. Carlson, C. L., & Tamm, L. (2000). Responsiveness of children with attention deficit-hyperactivity disorder to reward and response cost: Differential impact on performance and motivation. Journal of Consulting and Clinical Psychology, 68, 73-83.
11. Chabot, R. J., & Serfontein, G. (1996). Quantitative electroencephalographic profiles of children with attention deficit disorder. Biological Psychiatry, 40, 951-963.
12. Clarke, A. R., Barry, R. J., McCarthy, R., & Selikowitz, M. (2001). EEG-defined subtypes of children with attention-deficit=hyperactivity disorder. Clinical Neurophysiology, 112, 2098-2105.
13. Conners, C. K. (2001). Conners' Rating Scales-Revised. Toronto, Canada: Multi-Health Systems Inc.
14. Conners, C. K. (2002a). CPT-II, Continuous Performance Test II. Toronto, Canada: Multi-Health Systems Inc.
15. Conners, C. K. (2002b). Forty years of methylphenidate treatment in Attention-Deficit=Hyperactivity Disorder. Journal of Attention Disorder, 6, S17-S30.
16. Delis, D., Kaplan, E., & Kramer, J. (2001). Delis- Kalpan Executive Function System examiner's manual. San Antonio, TX: Harcourt Assessment, Inc.
17. Drechsler, R., Straub, M., Doehnert, M., Heinrich, H., Steinhausen, H. C., & Brandeis, D. (2007). Controlled evaluation of a neurofeedback training of slow cortical potentials in children with Attention Deficit=Hyperactivity Disorder (ADHD). Behavioral and Brain Functions, 26, 3-35.
18. Durston, S. (2003). A review of the biological bases of ADHD: What have we learned from imaging studies? Mental Retardation and Developmental Disability Research Reviews, 9, 184-195.
19. Egner, T., & Gruzelier, J. H. (2003). Ecological validity of neurofeedback: Modulation of slow wave EEG enhances musical performance. NeuroReport, 14, 1221-1224.
20. Egner, T., & Gruzelier, J. H. (2004). EEG biofeedback of low beta band components: Frequency-specific effects on variables of attention and event-related brain potentials. Clinical Neurophysiology, 115(1), 131-139.
21. Emslie, H., Wilson, F. C., Burden, V., Nimmo-Smith, I., & Wilson, B. A. (2003). Behavioral Assessment of the Dysexecutive Syndrome for Children manual. Bury St Edmunds, England: Thames Valley Test Company.
22. Gevensleben, H., Holl, B., Albrecht, B., Vogel, C., Schlamp, D., Kratz, O., et al. (2009). Is neurofeedback an efficacious treatment for ADHD? A randomized controlled clinical trial. Journal of Child Psychology & Psychiatry, 50, 780-789.
23. Hannay, J., & Lezak, M. (2004). The Neuropsychological examination: Interpretation. In M. Lezak, D. Howieson & D. Loring (Eds.), Neuropsychological assessment, 4th edition, (pp. 133-156). New York: Oxford University Press.
24. Heinrich, H., Gevensleben, H., Freisleder, F. J., Moll, G. H., & Rothenberger, A. (2004). Training of slow cortical potentials in attention-deficit=hyperactivity disorder: Evidence for positive behavioral and neurophysiological effects. Biological Psychiatry, 55, 772-775.
25. Himelstein, J., Newcorn, J. H., & Halperin, J. M. (2000). The neurobiology of attention-deficit hyperactivity disorder. Frontiers in Bioscience, 5, D461-D478.
26. Kaplan, E., Fein, D., Kramer, J., Delis, D. & Morris, R. (1999). WISC-III-PI manual. San Antonio, TX: Harcourt Assessment, Inc.
27. Kaufman, J., Birmaher, B., Brent, D., Rao, U., Flynn, C., Moreci, P., et al. (1997). Schedule for Affective Disorders and Schizophrenia for School-Age Children- Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. Journal of American Academy of Child & Adolescent Psychiatry, 36, 980-988.
28. Landers, D. M., Petruzzello, S. J., Salazar, W., Crews, D. J., Kubitz, K. A., Gannon, T. L., et al. (1991). The influence of electrocortical biofeedback on performance in pre-elite archers. Medicine & Science in Sports & Exercise, 23(1), 123-129.
29. Leins, U., Goth, G., Hinterberger, T., Klinger, C., Rumpf, N., & Strehl, U. (2007). Neurofeedback for children with ADHD: A comparison of SCP and Theta=Beta protocols. Applied Psychophysiology & Biofeedback, 32, 73-88.
30. Lévesque, J., Beauregard, M., & Mensour, B. (2006). Effect of neurofeedback training on the neural substrates of selective attention in children with attention-deficit=hyperactivity disorder: A functional magnetic resonance imaging study. Neuroscience Letters, 394, 216-221.
31. Linden, M., Habib, T., & Radojevic, V. (1996). A controlled study of the effects of EEG biofeedback on cognition and behavior of children with attention deficit disorder and learning disabilities. Biofeedback & Self Regulation, 21(1), 35-49. [Erratum, 1996, 21(3), 297]
32. Loo, S. K., & Barkley, R. A. (2005). Clinical utility of EEG in attention deficit hyperactivity disorder. Applied Neuropsychology, 12(2), 64-76.
33. Lubar, J. F., & Shouse, M. N. (1976). EEG and behavioral changes in a hyperkinetic child concurrent with training of the sensorimotor rhythm (SMR): A preliminary report. Biofeedback & Self Regulation, 1, 293-306.
34. Lubar, J. F., Swartwood, M. O., Swartwood, J. N., & O'Donnell, P. H. (1995). Evaluation of the effectiveness of EEG neurofeedback training for ADHD in a clinical setting as measured by changes in T.O.V.A. scores, behavioral ratings, and WISC-R performance. Biofeedback & Self Regulation, 20(1), 83-99.
35. Lubar, J. O., & Lubar, J. F. (1984). Electroencephalographic biofeedback of SMR and beta for treatment of attention deficit disorders in a clinical setting. Biofeedback & Self Regulation, 9(1), 1-23.
36. Maassen, G. H., Bossema, E., & Brand, N. (2009). Reliable change and practice effects: Outcomes of various indices compared. Journal of Clinical and Experimental Neuropsychology, 31, 339-352.
37. Manly, T., Robertson, I. H., Anderson, V., & Nimmo-Smith, I. (1999). TEA-CH: The Test of Everyday Attention for Children manual. Bury St Edmunds, UK: Thames Valley Test Company Limited.
38. Moher, D., Schulz, K. F., & Altman, D. G. (2001). The CONSORT statement: Revised recommendations for improving the quality of reports of parallelgroup randomised trials. Lancet, 357, 1191-1194.
39. MTA Cooperative Group. (1999). Moderators and mediators of treatment response for children With attention-deficit=hyperactivity disorder: The Multimodal Treatment Study of children with Attention-deficit=hyperactivity disorder. (1999). Archives of General Psychiatry, 56, 1088-1096.
40. Nieoullon, A., & Coquerel, A. (2003). Dopamine: Akey regulator to adapt action, emotion, motivation and cognition. Current Opinion Neurology, 16(Suppl. 2), S3-S9.
41. Nigg, J. T. (2005). Neuropsychological theory and findings in Attention-Deficit=Hyperactivity Disorder: The state of the field and salient challenges for the coming decade. Biological Psychiatry, 57, 1424-1435.
42. Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007). The worldwide prevalence of ADHD: A systematic review and metaregression analysis. American Journal of Psychiatry, 164, 942-948.
43. Quinn, D., Bode, T., Reiz, J., Donnelly, G. A. E., & Darke, A. (2007). Release methylphenidate and immediate-release methylphenidate in children with attention-deficit=hyperactivity disorder. Journal of Clinical Pharmacology, 47, 760-766.
44. Rossiter, T. (2004). The effectiveness of neurofeedback and stimulant drugs in treating AD=HD: Part I. Review of methodological issues. Applied Psychophysiology & Biofeedback, 29, 95-112.
45. Snyder, S. M., & Hall, J. R. (2006). A meta-analysis of quantitative EEG power associated with attention-deficit hyperactivity disorder. Journal of Clinical Neurophysiology, 23, 440-455.
46. Sterman, M. B., & Egner, T. (2006). Foundation and practice of neurofeedback for the treatment of epilepsy. Applied Psychophysiology and Biofeedback, 31(1), 21-35.
47. Swanson, J., Arnold, L. E., Kraemer, H., Hechtman, L., Molina, B., Hinshaw, S., et al. (2008a). Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: Executive summary. Journal of Attention Disorders, 12(1), 4-14.
48. Swanson, J., Arnold, L. E., Kraemer, H., Hechtman, L., Molina, B., Hinshaw, S., et al. (2008b). Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details. Journal of Attention Disorders, 12(1), 15-43.
49. Thompson, L., & Thompson, M. (1998). Neurofeedback combined with training in metacognitive strategies: Effectiveness in students with ADD. Applied Psychophysiology & Biofeedback, 23, 243-263.
50. Wagner, K. D. (2002). Management of treatment refractory attention-deficit=hyperactivity disorder in children and adolescents. Psychopharmacology Bulletin, 36(1), 130-142.
51. Wechsler Abbreviated Scale of Intelligence. (1999).WASI Manual. San Antonio, TX: HarcourtAssessment.
52. Willis, W. G., & Weiler, M. D. (2005). Neural substrates of childhood attention-deficit=hyperactivity disorder: Electroencephalographic and magnetic resonance imaging evidence. Developmental Neuropsychology, 27(1), 135-182.